Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024)
Biolife Solutions' (BLFS) quarterly Liabilities from Discontinued Operations came in at 616000.0 in Q4 2024, down 90.53% year-on-year from 6503000.0 in Q1 2024, and down 90.53% on a QoQ basis from 6503000.0 in Q4 2023.
Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Biolife Solutions (BLFS) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 616000.0 in Q4 2024.
- On a quarterly basis, Liabilities from Discontinued Operations fell 90.53% year-over-year to 616000.0 in Q4 2024; TTM through Dec 2024 was 616000.0, a 90.53% decrease from a year earlier, with the FY2024 full-year figure at 616000.0, down 90.53% from the prior year.
- Liabilities from Discontinued Operations for Q4 2024 stood at 616000.0, down from 6503000.0 in the prior quarter.
- Over the last five years, Liabilities from Discontinued Operations for BLFS reached as high as 6503000.0 in Q4 2023 and fell as low as 616000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 616,000.00 |
| Dec 31, 2024 | 616,000.00 |
| Dec 31, 2023 | 6.50 Mn |
| Dec 31, 2023 | 6.50 Mn |